XML 21 R8.htm IDEA: XBRL DOCUMENT v3.8.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2017
Sep. 30, 2016
Operating activities:    
Net income $ 230,473 $ 184,824
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 285,040 294,634
Debt premium and discount amortization (4,371) (10,630)
Deferred financing cost amortization 5,283 5,827
Above- and below-market lease intangible amortization (23,012) (29,471)
Provisions for impairment 27,383 1,971
Gain on disposition of operating properties 54,920 10,232
Gain on disposition of unconsolidated joint venture interest (4,556) 0
Equity based compensation 7,838 8,041
Other 1,836 797
(Gain) loss on extinguishment of debt, net (494) 937
Changes in operating assets and liabilities:    
Receivables (15,675) 4,042
Deferred charges and prepaid expenses (41,760) (33,101)
Other assets (3,753) 350
Accounts payable, accrued expenses and other liabilities 11,801 3,202
Net cash provided by operating activities 421,113 421,191
Investing activities:    
Improvements to and investments in real estate assets (140,036) (135,868)
Acquisitions of real estate assets 111,790 6,733
Proceeds from sales of real estate assets 228,680 31,068
Proceeds from sale of unconsolidated joint venture interest 12,369 0
Purchase of marketable securities (23,998) (35,172)
Proceeds from sale of marketable securities 20,640 31,622
Net cash used in investing activities (14,135) (115,083)
Financing activities:    
Repayment of debt obligations and financing liabilities (396,356) (865,918)
Repayment of borrowings under unsecured revolving credit facility (548,000) (805,000)
Proceeds from borrowings under unsecured revolving credit facility 426,000 481,000
Proceeds from unsecured term loan and notes 1,193,916 1,094,648
Repayment of borrowings under unsecured term loan (790,000) 0
Deferred financing costs (11,179) (17,698)
Distributions to common stockholders (238,106) (220,627)
Distributions to non-controlling interests (1,390) (3,492)
Repurchase of common shares in conjunction with equity award plans (2,714) (3,206)
Net cash used in financing activities (367,829) (340,293)
Change in cash, cash equivalents and restricted cash 39,149 (34,185)
Cash, cash equivalents and restricted cash at beginning of period 102,869 110,990
Cash, cash equivalents and restricted cash at end of period 142,018 76,805
Reconciliation to consolidated balance sheets    
Cash, cash equivalents and restricted cash at end of period 102,869 110,990
Supplemental disclosure of cash flow information:    
Cash paid for interest, net of amount capitalized of $2,268 and $1,918 176,524 183,505
Brixmor Operating Partnership LP    
Operating activities:    
Net income 230,473 184,824
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization 285,040 294,634
Debt premium and discount amortization (4,371) (10,630)
Deferred financing cost amortization 5,283 5,827
Above- and below-market lease intangible amortization (23,012) (29,471)
Provisions for impairment 27,383 1,971
Gain on disposition of operating properties 54,920 10,232
Gain on disposition of unconsolidated joint venture interest (4,556) 0
Equity based compensation 7,838 8,041
Other 1,836 797
(Gain) loss on extinguishment of debt, net (494) 937
Changes in operating assets and liabilities:    
Receivables (15,675) 4,042
Deferred charges and prepaid expenses (41,760) (33,101)
Other assets (3,753) 350
Accounts payable, accrued expenses and other liabilities 11,801 3,202
Net cash provided by operating activities 421,113 421,191
Investing activities:    
Improvements to and investments in real estate assets (140,036) (135,868)
Acquisitions of real estate assets 111,790 6,733
Proceeds from sales of real estate assets 228,680 31,068
Proceeds from sale of unconsolidated joint venture interest 12,369 0
Purchase of marketable securities (23,995) (35,163)
Proceeds from sale of marketable securities 20,640 31,622
Net cash used in investing activities (14,132) (115,074)
Financing activities:    
Repayment of debt obligations and financing liabilities (396,356) (865,918)
Repayment of borrowings under unsecured revolving credit facility (548,000) (805,000)
Proceeds from borrowings under unsecured revolving credit facility 426,000 481,000
Proceeds from unsecured term loan and notes 1,193,916 1,094,648
Repayment of borrowings under unsecured term loan (790,000) 0
Deferred financing costs (11,179) (17,698)
Partner distributions (242,209) (227,348)
Net cash used in financing activities (367,828) (340,316)
Change in cash, cash equivalents and restricted cash 39,153 (34,199)
Cash, cash equivalents and restricted cash at beginning of period 102,835 110,968
Cash, cash equivalents and restricted cash at end of period 141,988 76,769
Reconciliation to consolidated balance sheets    
Cash, cash equivalents and restricted cash at end of period $ 102,835 $ 110,968